Snapshot from Aug 25, 2026 at 07:00 UTC. For live data and tracking: View Live

United States — National Institutes of Health & Biogen

7 shared events · Importance 3 · Last updated Aug 07, 2026

Importance
3
Shared Events
7
Actions
0
Sentiment
0
Live sentiment trends, interaction importance charts, and action volume tracking available on the Ergen Dashboard
65
Tech
United States — National Institutes of Health: NIH funded the Pre-fALS study and provided grants supporting the research.
Biogen: Biogen's drug Tofersen is being evaluated in the ATLAS trial for pre-symptomatic ALS, potentially expanding its market.
Jul 27, 2026 · 12 articles
55
Tech
United States — National Institutes of Health: NIH funded the Alzheimer's Tau Platform at UCSF, supporting research into anti-tau therapies.
Biogen: Biogen's diranersen showed promising Phase II results, slowing cognitive decline by 26% in early Alzheimer's. The company plans a Phase III trial, positioning it as a leader in tau-targeting therapies.
Jul 14, 2026 · 22 articles
26
Business
United States — National Institutes of Health: Parent of United States — National Institute on Aging; no direct impact.
Biogen: Biogen is a partner in Leqembi commercialization; the sales results contribute to its Q2 2026 report.
Jul 29, 2026 · 6 articles
24
Business
United States — National Institutes of Health: Parent agency of NIA, indirectly supporting research.
Biogen: Joint development and commercialization partner for lecanemab; benefits from increased sales.
Aug 24, 2026 · 6 articles
12
Business
United States — National Institutes of Health: The United States — National Institutes of Health funds the Alzheimer's Clinical Trial Consortium, which provides infrastructure for clinical trials, including those involving Lecanemab.
Biogen: Biogen is a joint development and commercialization partner for Lecanemab, participating in clinical studies. While not the primary focus of this sales forecast, it benefits from the drug's success.
May 25, 2026 · 7 articles
0
Tech
Biogen: Biogen is a funding partner for the project, supporting the research into Alzheimer s disease biomarkers.
Feb 19, 2026 · 6 articles
0
Regulatory
May 08, 2026 · 14 articles
ERGEN INTELLIGENCE
Explore this relationship live

Track how United States — National Institutes of Health and Biogen interact across events, view sentiment trends, and discover connected entities.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.